Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-715-3 | CAS number: 55589-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- multi-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1973-Dec 01 through 1976-Dec-13
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Scientifically reliable study with sufficient information for evaluation and assessment considering the date of study and report. Compared to current guideline requirements fewer reproductive and developmental parameters were examined but F1b and F2b and F3a/b generations were included and examined including parameters of subacute toxicity and teratogenicity.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 976
- Report date:
- 1976
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Deviations:
- yes
- Remarks:
- 3 generations instead of two, including teratogenicity parts, top dose exceeded current limit dose of 1000 mg/kg bw/day
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- no
- Remarks:
- Study performed prior to implementation of GLP
- Limit test:
- no
Test material
- Reference substance name:
- 6-methyl-1,2,3-oxathiazine-4(3-H)-one-2,2-dioxide potassium salt
- IUPAC Name:
- 6-methyl-1,2,3-oxathiazine-4(3-H)-one-2,2-dioxide potassium salt
- Reference substance name:
- 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, potassium salt
- EC Number:
- 259-715-3
- EC Name:
- 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, potassium salt
- Cas Number:
- 55589-62-3
- Molecular formula:
- C4H5NO4S.K
- IUPAC Name:
- potassium 6-methyl-2,2,4-trioxo-3,4-dihydro-1,2λ⁶,3-oxathiazin-3-ide
- Reference substance name:
- Acesulfame potassium
- IUPAC Name:
- Acesulfame potassium
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report):Hoe 0-95 K
- Substance type: sweetener
- Physical state: crytsalline powder
- Analytical purity: 99.8%
- Impurities (identity and concentrations): Flouride < 1 pm, calcium 10 - 20 ppm
- Lot/batch No.: 4 batches not further specified
- Stability under test conditions: stable
Constituent 1
Constituent 2
Constituent 3
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Civo colony, Zeist, The Netherlands
- Age at study initiation: jung adult (P) x 12 wks; weanling (F1a/1b)x10 wks; weanlings (F2a/2b) x 10 wks, weanlings (F3a/3b) x 4 wks
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g
- Fasting period before study: no
- Housing: 5 rats/cage
- Use of restrainers for preventing ingestion: not applicable
- Diet: ad libitum (standard laboratory stock diet)
- Water: ad libitum (tap water)
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24-26° C
- Humidity (%): no data
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): 12h /12 h
IN-LIFE DATES:
From: 1973-Oct-(day not stated)
To: not stated
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: diet
- Details on exposure:
- DIET PREPARATION
- Rate of preparation of diet (frequency): every 2 - 3 weeks
- Mixing appropriate amounts with (Type of food): laboratory stock diet
- Storage temperature of food: ambient temperature - Details on mating procedure:
- - M/F ratio per cage:1:1
- Length of cohabitation:3 weeks
- Proof of pregnancy: no data
- After successful mating each pregnant female was caged (how): individually until litters were weaned
- Any other deviations from standard protocol: see further details on study schedule - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- Not applicable
- Duration of treatment / exposure:
- Through three succesful generations (F0, F1a/b, F2 a/b, F3a/b). See further details on study design
- Frequency of treatment:
- Daily
- Details on study schedule:
- See further details on study design
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 0.3%, 1.0%, 3.0% (0, 3000, 10000, 30000 ppm (corresponding to about 150, 500, 1500 mg/kg bw/day)
Basis:
nominal in diet
- No. of animals per sex per dose:
- F0: 20 males per group, 30 females per group
Further details see further details on study design - Control animals:
- yes, plain diet
- Details on study design:
- - Dose selection rationale:
From a previous sub-chronic toxicity study with rats it appeared that the feeding of Hoe 0-95 K at the very high dietary level of 10% only caused slight growth depression, caecal enlargment and increased relative weights of the liver and kidneys, not accompanied by histo-logical changes
No adverse effects an foetuses were noticed when the compoundwas administered to pregnant rats at levels up to 3% in the diet.
- Other:
The study started with 80 male and120 female, newly weaned, albino rats from the CIVO-colony of Wistar origin (F0 -generation).
The animals were housed in suspended, screen-bottomed stainless steel cages in a well ventilated room at 24-26° C. Groups of five rats of the same sex were housed in each cage. Each of the diets was fed to20 males and 30 females. Diets and tap water were constantly available. Individual body weights were recorded at week 0, 2, 4, 6, 8, 10, 12 and20. At week 12 and 20 the rats were mated in groups of 5 males and 10females on the same diet, to produce two successive litters (Fla and Flb respectively). After a mating period of three weeks the females were caged individually until the litters had been weaned. Records were made of the number of pups in each litter and of the total weight of the litter at day 1, 10 and 20. Litters containing more than eight siblings were randomly culled to eight, in order to equalize the stress of lactation among the dams.
At weaning age the F1a-litters were used to select the rats for a chronic toxicity/carcinogenicity study with the same test compound. The remaining weanlings were discarded.
The reproduction study was continued with 10 male and 20 female parent rats (F0) and the remaining 10 males and 10 females of each group ware killed at week 21 to examine the weights and the histological appearance of the liver, kidneys and caeca.
At weaning age of the F1b-litters 10 males and 20 females of each diet group were selected from as many litters as possible and maintained on the diet their parents had received. The Flb-rats were used to produce the F2a- and F2b-litters, the F2b-rats for rearing the F3-,andF3b-litters. Observations on litters were the same as described for theF0 -generation. From the F2b- and F3a-litters, 15 females and 5 males of each dosage group were used for teratological studies
After weaning their second litters, the mothers were sacrificedand the uterus was treated with ammonium sulphide solution for stainingand counting implantation sites.
Conduct of the 4-week feeding study with the F3b-litters
At weaning age of the F3b-litters, 10 males and 10 females of each diet group were selected from as many litters as possible, and continued on the same diet for a 4-week feeding study. Individual body weights were recorded weekly. The food consumption of each group was measured continuously.
In week 4 all surviving rats were killed by decapitation and examined grossly for pathological changes. The following organs were weighed: heart, kidneys, liver, spleen, brain, gonads, thymus, thyroid, adrenal and caecum (filled and empty). Samples of these organs and of a wide rang of other organs were fixed in a 4% neutralized formaldehyde solution.
Detailed microscopic examination was performed on all male and female rats of the highest dose group and of the control group. Haematoxylin and eosin stained paraffin sections of the organs weighed and also of the following organs were examined: lung, trachea, salivary glands, urinary bladder, skeletal muscle, thoracic aorta, oesophagus, gastro-intestinal tract (6 levels), pancreas and axillary and mesenteric lymph nodes.
Conduct of the teratology study
At weaning age of the F2b and F3alitters, 15 females and 5 males of each dosage group were selected and maintained on the various diets until used for teratology studies. When 12 weeks old, these selected animals were mated (1 male was caged with 3 females). Vaginal smears were taken daily to determine whether mating had occurred. The day of detection of spermatozoa in the vaginal smear was considered as day 0 of the gestation period. Then the pregnant females were individually caged.
On day 21 of pregnancy the dams were killed by decapitation. Both ovaries and uterus were removed. The number of corpora lutea were counted and the ovaries were weighed. The foetuses were removed from the uterus, dried of amniotic fluid, weighed, examined for macroscopic abnormalities, sexed and fixed in 70% ethanol for 4 days or in Bouin's fluid for at least one week. Intra-uterine dead embryos and foetuses and the number and position of the implantation sites in both uterine horns were recorded. The empty uterus was weighed.
Every third foetus, taken from the uterus was fixed in 90% ethanol after being eviscerated, skinned and stripped of most subcutaneous fat. Thereafter these foetuses were cleared and stained with Alizarine Red S according to the method of Dawson (1926) for examination of the skeleton.
The remaining foetuses, fixed in Bouin's fluid, were transferred to 70% ethanol before being cut into a number of slices according to the technique of Wilson (1965) for examination of the soft tissues.
All examinations for foetal abnormalities were carried out under a dissecting microscope. Soft tissue and skeletal examinations were restricted to the foetuses of the highest and lowest dose groups and the control group. - Positive control:
- No
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: F0: week 0, 2, 4, 6, 8, 10, 12 and 20
FOOD CONSUMPTION
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No - Oestrous cyclicity (parental animals):
- No measured
- Sperm parameters (parental animals):
- Parameters examined in all male parental generations:
testis weight, testis and epididymis histopathlogy - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 8 pups/litter (4/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in [F1 / F2 / F3] offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities
GROSS EXAMINATION OF DEAD PUPS:
yes, for external and internal abnormalities - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals, as soon as possible after the last litters in each generation were produced (details see further details on study design)
- Maternal animals: All surviving animals (details se further details on study design)
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera. (details se further details on study design)
HISTOPATHOLOGY:
F3b litter: lung, trachea, salivary glands, urinary bladder, skeletal muscle, thoracic aorta, oesophagus, gastro-intestinal tract (6 levels), pancreas and axillary and mesenteric lymph nodes.
ORGAN WEIGHTS:
F0: liver, kidney, caecum (filled and empty)
F3b litter: heart, kidneys, liver, spleen, brain, gonads, thymus, thyroid, adrenal and caecum (filled and empty). - Postmortem examinations (offspring):
- See further design of study design.
- Statistics:
- Student's t -test: all data except mortality, skeletal and visceral anormalities
Chi-square test: mortality, skeletal and visceral anormalities
Wilcoxon test: body weight F3b generation
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
Details on results (P0)
No abnormalities of condition or behaviour were observed in any ofthe diet groups, and in any of the successive generations.
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
The body weights of males were decreased in the 3% group in the F0- and F1b-generation. This effect occurred also at the 1% level, but only in males of the F0-generation. The growth figures in females were generally comparable in all groups, but in the F1-generation slightly decreased body weights were observed in the highest dose group. There were no significantly decreased body weights in the highest dose groupof the F2-generation parent rats.
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
The percentage of females which casted a litter was very high in all groups throughout the study. The mean number of young per litter did not show any significant differences amongst the groups.
ORGAN WEIGHTS (PARENTAL ANIMALS)
F0 rats: A slight increase in the weight of the filled caecum was observedin males of the highest dose group. The relative weights of the liver and kidneys were comparable in the various groups
GROSS PATHOLOGY (PARENTAL ANIMALS)
Gross autopsy findings of the organs weighed did not reveal any abnormalities, attributable to the feeding of the test substance
HISTOPATHOLOGY (PARENTAL ANIMALS)
Microscopical examination of the organsweighed did not reveal any abnormalities, attributable to the feeding ofthe test substance
OTHER FINDINGS (PARENTAL ANIMALS)
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 10 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
- Dose descriptor:
- NOAEL
- Effect level:
- 30 000 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
- Remarks on result:
- other: Generation: F3a/b (migrated information)
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Details on results (F1)
No effetc
CLINICAL SIGNS (OFFSPRING)
No efefct
BODY WEIGHT (OFFSPRING)
F3b: The body weight was slightly decreeased in males but not in females at the high dose.
ORGAN WEIGHTS (OFFSPRING)
F3b: no effect
GROSS PATHOLOGY (OFFSPRING)
No substance-related effect.
Effect levels (F1)
open allclose all
- Dose descriptor:
- NOAEL
- Generation:
- F1a
- Effect level:
- 10 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
- Dose descriptor:
- NOAEL
- Generation:
- F1b
- Effect level:
- 10 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
Results: F2 generation
Effect levels (F2)
open allclose all
- Dose descriptor:
- NOAEL
- Generation:
- F2a
- Effect level:
- 10 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
- Dose descriptor:
- NOAEL
- Generation:
- F2b
- Effect level:
- 10 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: body weight
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
Results of the 4 -week study with F3b rats:
No deaths or abnormalities of condition or behaviour were observedduring the 4 -wek experiment in any of the groups.
Body weights were slightly decreased in males of the highest dose group. In females body weights of all groups were comparable. Food consumption (during the first two weeks) and food efficiency were lowest in the top-dose group.
At 0.1% statistically significant differences with the controls occurred in the relative weights of the kidneys, testis and thymus. However, as these changes were not observedat the two higher feeding levels, they were considered incidental findings.
Filled caecum weights were slightly increased in males at 1.0% and 3.0% and in females at 3.0% Empty caecum weights tended to increase in these groups.
At autopsy, no pathological changes attributable to the ingestion of the test substance were observed, either in males or in females.
Microscopic examination did not reveal treatment-related changes.
Results of the teratology study with F2b and F3a rats:
There was no treatment-related effect on body weight/body weight gain and food intake.
There was no treatment-related or biologically relevant effect on necropsy, oragn weights or litter data.
In both generations, no significant differences in anomalies between test and control groups were observed. The anomalies noted were regularly observed in the strain of rats used.
Type and incidence of skeletal anomalies revealed no substance-relationship.
Applicant's summary and conclusion
- Conclusions:
- The multigeneration study with Acesulfame potassium in rats was carried in male and female Wistar rats at dietary levels of 0, 0.3, 1.0 and 3.0% for three successive generations, each comprising two consecutive litters. A teratogenicity study was conducted with 15 females per group of the F2b and F3a generations. Rats from the F3b generation were submitted to clinical and pathological examination. Pups from the F1a litters were used for a chronic toxicity/carcinogenicity study at the same dietary levels as the parents. Fertility, number of young per litter, birth weight, growth rate and mortality during the lactation period were not adversely affected and there were no indications of increased mortality in utero. Growth rate was slightly decreased in the top dose group of the F0 and F1 generations. In the teratogenicity studies, no adverse effects were seen in appearance, food consumption, autopsy of the dams, organ weights, or litter data; no visceral or skeletal abnormalities attributable to the treatment were observed.
The NOAEL for fertility and reproductive performance was 3.0% (30000 ppm corresponding to about 1500 mg/kg bw/day) a dose level exceeded the current limit dose of 1000 mg/kg bw/day.
The NOAEL for systemic parental toxicity was 1.0% (10000 ppm corresponding to about 500 mg/kg bw/day) due to slight reductions in body weight/body weight gain.
The NOAEL for pre-, post-natal developmental toxicity including teratogenicity was 3.0% (30000 ppm corresponding to about 1500 mg/kg bw/day) a dose level exceeded the current limit dose of 1000 mg/kg bw/day. - Executive summary:
Acesulfame potassium was investigated for its effect on fertility, reproductive performance, pre- and postnatal development in male and female Wistar rats at dietary levels of 0, 0.3, 1.0 and 3.0% in three successive generations, each comprising two consecutive litters. A teratogenicity study was conducted with 15 females per group of the F2b and F3a generations. Rats from the F3b generation were submitted to clinical and pathological examination. Pups from the F1a litters were used for a chronic toxicity/carcinogenicity study at the same dietary levels as the parents.
This study is assessed as appropriate and valid since it was performed comparable to an internationally accepted testing guideline with deviations that can be considered as minor. Reporting, assessment and data presentation in the study report was considered as appropriate considering the date of study and report.
Fertility, number of young per litter, birth weight, growth rate and mortality during the lactation period were not adversely affected and there were no indications of increased mortality in utero.
Growth rate was slightly decreased in the top dose group of the F0 and F1 generations. In the teratogenicity studies, no adverse effects were seen in appearance, food consumption, autopsy of the dams, organ weights, or litter data; no visceral or skeletal abnormalities attributable to the treatment were observed.
In the four-week feeding study with the F3b-generation rats body weights and food efficiency figures were slightly decreased in males at the highest dose level. The relative weights of the caecum were slightly increased in both sexes of the high-dose group and in males of the mid-dose group. These findings were considered to represent an adaptive condition. Gross and microscopic examination did not reveal any treatment-related pathological changes.
In the teratogenicity studies general appearance, food consumption and autopsy findings, organ weights 'and litter data were not adversely affected at any dose level. Visceral and skeletal examination of fetuses did not reveal any teratogenic effects attributable to the feeding of the test substance.
The only effects of the test substance which were considered treatment-related consisted of inconsistent, slight decreases in body weights in the top-dose group, and a slight increase in the weight of the caecum.
Conclusion:
The NOAEL for fertility and reproductive performance was 3.0% (30000 ppm corresponding to about 1500 mg/kg bw/day) a dose level exceeded the current limit dose of 1000 mg/kg bw/day.
The NOAEL for systemic parental toxicity was 1.0% (10000 ppm corresponding to about 500 mg/kg bw/day) due to slight reductions in body weight/body weight gain.
The NOAEL for pre-, post-natal developmental toxicity including teratogenicity was 3.0% (30000 ppm corresponding to about 1500 mg/kg bw/day) a dose level exceeded the current limit dose of 1000 mg/kg bw/day.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.